跳至主要内容
临床试验/CTRI/2021/02/030882
CTRI/2021/02/030882招募中4 期

Study of Inj. Sepsivac® in gram negative sepsis

Medanta The Medicity0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients presumed to have gram-negative sepsis(Clinically Diagnosed)
  • 2.Age between 18 to 65 years (both inclusive)
  • 3.Agrees to Provide Consent

排除标准

  • 1.History of allergic reactions attributed to Inj. Sepsivac® or any of its excipients
  • 2. Pregnant and lactating women
  • 3. Generalized septic skin conditions
  • 4. Not willing to provide Consent
  • 5. Patient not clinically diagnosed with Gram-ve sepsis

研究者

相似试验